Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Azoulay Salomon, holds the title of Chief Medical Officer at MBX Biosciences, Inc..
On 2026-08-04, the insider transacted 370 shares.The shares were transacted at a weighted average price of $65.77 per share, resulting in a total market-relevant value of $24K.
Azoulay Salomon (Chief Medical Officer) sold $24K of $MBX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.